Biotech

Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst

Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst

FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin

FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin

FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit

Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments

Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit

Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments

Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments

ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results

ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs

Biotech Recent News

Eli Lilly Loses Appeal Over Medicaid Drug Pricing Fraud Case

Eli Lilly Loses Appeal Over Medicaid Drug Pricing Fraud Case

A U.S. appeals court upheld a $183.7 million judgment against Eli Lilly in a whistleblower case, finding the company misreported drug prices and shorted Medicaid rebates.

Jim Cramer Says Johnson & Johnson Stock Could Power Through $200 Next

Jim Cramer Says Johnson & Johnson Stock Could Power Through $200 Next

Johnson & Johnson investors focus on its pharma strength, legal strategy shift, and growth in medical devices amid sector challenges.

Why Is HCW Biologics Stock Surging 102% Overnight?

Why Is HCW Biologics Stock Surging 102% Overnight?

HCW Biologics' stock jumped 102.72% to $6.73 after the company revealed the successful development of second-generation T-cell engagers for solid tumors.

Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug

Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug

Revolution Medicines reports positive results from daraxonrasib trials in metastatic pancreatic cancer, with strong response rates and consistent safety data.

Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential

Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential

Maze's MZE782 showed strong Phase 1 results, supporting once- or twice-daily dosing with increased amino acid excretion and no serious side effects.

Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data

Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data

Silexion's SIL204 showed strong anti-tumor effects in preclinical tests, reaching major metastasis sites in pancreatic cancer models at human-relevant doses.

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

Merck's Capvaxive vaccine showed strong immune responses and a comparable safety profile to PPSV23 in high-risk children during the Phase 3 STRIDE-13 trial.